Valuation (48%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -1.21 | 19.21 |
| PEG Ratio (TTM) | 0.01 | 16.39 |
| P/S Ratio (TTM) | 1.89 | 6.95 |
| P/B Ratio (TTM) | 0.76 | 5.99 |
| P/FCF Ratio (TTM) | 11.27 | 17.74 |
| Price to 5YR AVG Earnings Ratio | N/A | 98.50 |
| Price to 5YR AVG FCF Ratio | N/A | 33.03 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -28.47% | 0.45% |
| ROE (TTM) | -50.15% | 8.86% |
| Net Profit Margin (TTM) | -156.66% | 2.94% |
| ROIC 5YR AVG | N/A | 11.51% |
Growth (27%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -972.04% | -59.97% | N/A |
| Revenue | 1.20% | 37.60% | N/A |
| Net Income | -986.48% | -15.67% | N/A |
| Cash Flow | 41.34% | 19.08% | N/A |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.31 | 2.45 |
| Quick Ratio (TTM) | 2.33 | 2.27 |
| D/E Ratio (TTM) | 0.39 | 0.73 |
| Interest Coverage (TTM) | -26.40 | 6.45 |
| Piotroski F-Score | 4 | 5 |
| Altman Z-Score | N/A | 7.33 |
| LTL to 5YR AVG FCF | N/A | 1.12 |
| Shares Outstanding Growth 5YR AVG | N/A | 4.81% |